Aidoc key facts
as of Oct 2026- Developer of a decision support platform designed to empower physicians to enhance patient care outcomes.
- Aidoc is valued at approximately $686.4M as of Oct 2026 (last reported valuation).
- It has raised $420.3M; the latest was Later Stage VC ($150.0M) in Jul 2025.
- Notable investors include Google for Startups, General Catalyst, Microsoft for Startups, NVentures (Santa Clara), Amazon Web Services — 25 tracked in total.
- Status: Privately Held (backing).
Aidoc's last reported valuation, Jun 2022. Nothing priced has surfaced since.
- ·The complete investor list: 25 names
- ·Watch Aidoc: the Monday email on marks, rounds and moves
Aidoc funding rounds
No funding rounds for Aidoc are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Aidoc
25+Aidoc valuation
Aidoc's last reported valuation was $686 million in Jun 2022. No priced round, secondary trade or fund mark has surfaced since.
Aidoc investors
25 investors are on record for Aidoc, including Google for Startups, General Catalyst, Microsoft for Startups and NVentures (Santa Clara). By type, the record holds 5 venture capital firms and 1 growth equity firm.
About Aidoc
Developer of a decision support platform designed to empower physicians to enhance patient care outcomes. The company's platform processes medical imaging and patient data using advanced artificial intelligence algorithms to detect critical anomalies and activate the appropriate care pathway within the health system, enabling radiology, cardiology, neurovascular and vascular physicians to get comprehensive clinical data for patient outcomes.
- Sector
- Healthcare
- HQ
- Tel Aviv, NY, Israel
- Founded
- 2016
- Employees
- 488
- Website
- aidoc.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.